FDA Oncology

FDA Oncology Center of Excellence expedites medical product development to improve the lives of people with cancer.

[FDA Oncology @FDAOncology]

🚨 We're moving!
To stay up to date on the latest news, announcements, and updates, follow us at @FDADrugs.
This account will no longer be actively updated and will be deactivated on 9/12, so make the switch today—we'll see you there!

[FDA Oncology @FDAOncology]

NEWS: @US_FDA approves a treatment for prostate cancer. https://t.co/S8QXjcJSL2

[FDA Oncology @FDAOncology]

Fewer than 5% of cancer patients receiving treatment have the opportunity to participate in a clinical trial due to restrictions on who is eligible to participate. Today FDA is issuing guidance to broaden the criteria for participation.
https://t.co/6EbZErbswT

[FDA Oncology @FDAOncology]

NEWS: @US_FDA approves a treatment for ROS1-positive non-small cell lung cancer.

https://t.co/rqaSYMhe45

[FDA Oncology @FDAOncology]

July is #SarcomaAwarenessMonth! Sarcoma is a rare cancer affecting bones and soft tissues. CURE ID, an FDA & NIH platform, collects real-world treatment experiences for sarcomas and other rare diseases. Make a difference by sharing your experience at: https://t.co/2dfLV5RdRn

[FDA Oncology @FDAOncology]

NEWS: @US_FDA approves a treatment for HR-positive, HER2-negative breast cancer.
https://t.co/1uqoD5ukW7

[FDA Oncology @FDAOncology]

NEWS: @US_FDA grants traditional approval to a treatment for locally advanced or metastatic RET fusion-positive solid tumors.
https://t.co/OVakLClYse

[FDA Oncology @FDAOncology]

NEWS: @US_FDA approves a treatment for muscle invasive bladder cancer.
https://t.co/FS0FNav8Lh

[FDA Oncology @FDAOncology]

NEWS: @US_FDA has approved a subcutaneous injection for multiple myeloma across various stages of treatment. https://t.co/W34DYQnnmk

[FDA Biologics @FDACBER]

A milestone for patients with blood cancers: Today, FDA approved the first Treg cell-based immunotherapy to improve chronic GVHD-free survival following hematopoietic stem cell transplantation in adults. Find out more: https://t.co/bNY4G9H0rm

[FDA Oncology @FDAOncology]

#FDA approves sacituzumab govitecan-hziy for two indications in adults with triple-negative breast cancer. https://t.co/BY0GoZPzdO

[FDA Oncology @FDAOncology]

#FDA approves a treatment for HR-positive, HER2-positive breast cancer. https://t.co/1bzMNxqTGq

[FDA Oncology @FDAOncology]

#OCE will host a virtual Conversations on Cancer discussion to explore the differences between religion and spirituality and how increasing religious literacy and spiritual care may impact overall patient care. #ConversationsonCancer
https://t.co/Q3Fy1cSw02

[FDA Oncology @FDAOncology]

FDA's Oncology Center of Excellence facilitated 70 cancer therapy approvals in 2025, including 17 new molecular entities. To learn more about how we’re advancing cancer care, explore OCE’s 2025 annual report: https://t.co/t9vrylxS2r

[FDA Oncology @FDAOncology]

#FDA approves a treatment for PTEN-deficient androgen pathway modulation-naïve or -sensitive prostate cancer. https://t.co/nDKDZ9ytXz

[FDA Oncology @FDAOncology]

#FDA approves an adjuvant treatment for renal cell carcinoma. https://t.co/nHRtGUmr4F

[FDA Oncology @FDAOncology]

Tomorrow! Join #FDAOncology for Conversations on Cancer:
Patients First = Project Facilitate
Project Facilitate helps patients and physicians navigate the Expanded Access pathway to investigational cancer therapies.
June 10th | 12:00 pm ET |Virtual event
https://t.co/a4YpOQAEwU

[FDA Oncology @FDAOncology]

Project Facilitate helps oncology professionals successfully submit expanded access requests.
To learn more, join #FDAOncology for Conversations on Cancer:
Patient First = Project Facilitate.
📅June 10, 2026 | 🕐 12:00 pm ET |💻 Virtual event
https://t.co/a4YpOQA6Hm

[FDA Oncology @FDAOncology]

Thank you @ASCO and the Patient Advocates who attended the “FDA United in Accelerating Progress for Patients” session. FDA celebrates National Cancer Survivors Month.

[FDA Oncology @FDAOncology]

Project Facilitate streamlines access to investigational therapies for patients facing life-threatening cancers.
Join the #FDAOncology Conversations on Cancer discussion:
Patient First = Project Facilitate.
📅 June 10, 2026 | 12:00 pm ET |💻 Virtual event
https://t.co/a4YpOQA6Hm